Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2015 13:53 ET | Source: The Chicago Council on Global Affairs

Survey: Americans Prioritize Affordability and Nutrition Over Non-GMO, Organic and Antibiotic-Free Foods

CHICAGO, Oct. 14, 2015 (GLOBE NEWSWIRE) -- Despite high-profile debates in the media about GMOs, organics and antibiotic-free food, the majority of Americans care most about the cost and nutrition of...
October 12, 2015 08:30 ET | Source: OpGen, Inc.

Data Show “Super Bug” Surveillance System Based on OpGen’s Acuitas(R) Resistome Test Can Identify Potential Outbreaks in Hospitals and Improve Infection Control

GAITHERSBURG, Md., Oct. 12, 2015 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN), an early-stage commercial molecular testing and bioinformatics company, today announced that new data from a...
October 09, 2015 15:30 ET | Source: Melinta Therapeutics

Melinta Therapeutics Presents Complete Delafloxacin Results from Phase 3 Study in Patients with Acute Bacterial Skin and Skin Structure Infections at ID Week

NEW HAVEN, CT and SAN DIEGO, Oct. 9, 2015 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, today announced...
May 19, 2015 16:00 ET | Source: Melinta Therapeutics

Melinta Therapeutics Study Demonstrates Significant Burden of Obesity on Patients' Recovery from Acute Bacterial Skin Infections

New Haven, CT, May 19, 2015 (GLOBE NEWSWIRE) -- Melinta Therapeutics today presented data that show the negative impact of obesity on patients' recovery from acute bacterial skin and skin structure...
May 19, 2015 07:00 ET | Source: Melinta Therapeutics, Inc.

Cempra Presenting Additional Data From the Phase 3 Oral Solithromycin Study in Community Acquired Bacterial Pneumonia at the American Thoracic Society Conference

CHAPEL HILL, N.C., May 19, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
April 30, 2015 16:04 ET | Source: Melinta Therapeutics, Inc.

Cempra Reports First Quarter 2015 Financial Results and Provides Corporate Update

CHAPEL HILL, N.C., April 30, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
April 23, 2015 07:30 ET | Source: Melinta Therapeutics, Inc.

Cempra to Report First Quarter 2015 Financial Results

CHAPEL HILL, N.C., April 23, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
April 09, 2015 12:02 ET | Source: Melinta Therapeutics

Melinta Therapeutics Shows that Health-Related Quality-of-Life is higher in ABSSSI Patients Deemed Cured vs Improved after End of Treatment

New Haven, CT, April 9, 2015 (GLOBE NEWSWIRE) -- Melinta Therapeutics today presented an evaluation of Health-Related Quality-of-Life (HRQL) in acute bacterial skin and skin structure infection...
February 09, 2015 08:00 ET | Source: Melinta Therapeutics

Melinta Therapeutics Secures up to $30 Million from Hercules Technology Growth Capital

New Haven, Conn, Feb. 9, 2015 (GLOBE NEWSWIRE) -- Melinta Therapeutics announced today that it has entered into a $30 million growth capital debt financing agreement with Hercules Technology Growth...
February 03, 2015 08:00 ET | Source: Melinta Therapeutics, Inc.

Cempra to Present at Three Upcoming Investor Conferences

CHAPEL HILL, N.C., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right